XETRA - Delayed Quote EUR

Darwin AG (7V0.DE)

30.20
+0.60
+(2.03%)
At close: May 23 at 5:36:18 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
18,169.02
--
18,169.02
218,711.73
111,321.48
Cost of Revenue
12,135.08
--
12,135.08
90,505.06
55,739.38
Gross Profit
6,033.94
--
6,033.94
128,206.67
55,582.10
Operating Expense
14,596.53
--
14,596.53
69,045.89
26,072.90
Operating Income
-8,562.59
--
-8,562.59
59,160.79
29,509.20
Net Non Operating Interest Income Expense
1,506.61
--
1,506.61
207.10
-7.53
Pretax Income
3,018.93
--
3,018.93
59,724.24
29,532.40
Tax Provision
2,979.22
--
2,979.22
16,849.35
7,943.80
Net Income Common Stockholders
39.71
--
39.71
45,074.89
19,388.60
Diluted NI Available to Com Stockholders
39.71
--
39.71
45,074.89
19,388.60
Basic EPS
15.02
--
0.01
15.02
6.46
Diluted EPS
15.02
--
0.01
15.02
6.46
Basic Average Shares
3,000.99
--
3,971.30
3,000.99
3,001.33
Diluted Average Shares
3,000.99
--
3,971.30
3,000.99
3,001.33
Total Operating Income as Reported
-3,743.39
--
-3,743.39
65,051.07
29,658.38
Total Expenses
-1,075.19
--
26,731.61
159,550.94
81,812.28
Net Income from Continuing & Discontinued Operation
39.71
--
39.71
42,874.89
21,588.60
Normalized Income
-8,523.97
--
-8,523.97
42,619.08
21,566.14
Interest Income
1,789.53
--
1,789.53
235.52
41.84
Interest Expense
282.92
--
282.92
28.42
49.37
Net Interest Income
1,506.61
--
1,506.61
207.10
-7.53
EBIT
3,301.85
27,401.12
3,301.85
59,752.66
29,581.78
EBITDA
13,472.54
--
13,472.54
73,412.54
30,235.99
Reconciled Cost of Revenue
12,135.08
--
12,135.08
90,505.06
55,739.38
Reconciled Depreciation
2,186.86
--
2,186.86
1,927.80
553.41
Net Income from Continuing Operation Net Minority Interest
39.71
--
39.71
42,874.89
21,588.60
Total Unusual Items Excluding Goodwill
10,074.92
--
10,074.92
356.35
30.73
Total Unusual Items
10,074.92
--
10,074.92
356.35
30.73
Normalized EBITDA
3,397.62
--
3,397.62
73,056.19
30,205.26
Tax Rate for Calcs
0
--
0
0
0
Tax Effect of Unusual Items
1,511.24
--
1,511.24
100.53
8.27
12/31/2021 - 8/2/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
 
88Q.DE 4basebio PLC
13.10
0.00%
 
BIO.DE Biotest Aktiengesellschaft
43.00
0.00%
 
9VC.DE Atai Life Sciences N.V.
1.7510
-2.40%
 
VX1.DE Vertex Pharmaceuticals Incorporated
383.45
-0.22%
 
AYJ.DE Valneva SE
2.9200
+2.24%
 
NP5.DE Newron Pharmaceuticals S.p.A.
8.03
-0.12%
 
BBZA.DE BB Biotech AG Ord
30.85
-0.32%
 
HPHA.DE Heidelberg Pharma AG
3.3100
-0.90%
 
FYB.DE Formycon AG
22.25
+0.45%